CLU and Alzheimer disease: Taken together with a growing amount of human genetic data linking various genes mediating lipid metabolism to AD (e.g., APOE4, ABCA7, CLU, TREM2), these published data as well as lipidomic data from our study lends strong support to the notion dysregulation of microglial lipid metabolism contributes to AD pathogenesis.